|
| | | Notification of Major Interest in Shares
|
|
| | | Result of General Meeting
|
|
| | | Total Voting Rights
|
|
| | | Verona Pharma successfully completes £3.25 million placing
|
|
| | | Notification of Major Interest in Shares
|
|
| | | Phase IIa RPL554 study reports positively for safety and bronchodilation in patients with mild to moderate COPD
|
|
| | | Exercise of Options
|
|
| | | VRP700 demonstrates significant anti-tussive effects in patients with chronic intractable coughing
|
|
| | | Interim Report For The Six Months Ended 30 June 2011
|
|
| | | Bronchodilation in asthmatics maintained with daily dosing of RPL554
|
|
| | | Rollover of Director Options
|
|
| | | Results of AGM
|
|
| | | AGM Statement
|
|
| | | Commencement of New Phase II Clinical Trial of RPL554 in Asthma
|
|
| | | Notice of AGM and Annual Report
|
|
| | | Appointment of WH Ireland as Joint Broker
|
|
| | | First COPD Trial with RPL554 begins in Rome
|
|
| | | Preliminary Unaudited Results for the 12 months ended 31 December 2010
|
|
| | | Total Voting Rights Update
|
|
| | | Issue of Equity
|
|
| | | Verona Pharma announces positive results for RPL554 in mild asthma at higher doses
|
|
| | | Verona Pharma applies for approval to test RPL554 in UK clinical trials
|
|
| | | Company Response to Share Price Movement
|
|
| | | Verona Pharma commences higher dose RPL554 clinical trial
|
|
| | | Proof of Concept Trials confirm RPL554 delivery possible via industry-standard inhaler devices
|
|
| | | Verona Pharma commences clinical trial of VRP700 for chronic cough
|
|
| | | Interim Report for the six months ended 30 June 2010
|
|
| | | Update on RPL554 and Cough Projects
|
|
| | | Grant of Options
|
|
| | | AGM Statement 3 June 2010
|
|
| | | 2009 Annual Report and Notice of AGM
|
|
| | | Preliminary Unaudited Results for year ended 31 December 2009
|
|
| | | Notice of Interest
|
|
| | | New Year Progress Report on Verona Pharma plc
|
|
| | | Application for admission of new Ordinary Shares
|
|
| | | Result of General Meeting
|
|
| | | Director's Shareholding
|
|
| | | Posting of Circular
|
|
| | | Form of Proxy Verona Pharma PLC -- General Meeting
|
|
| | | Issue of equity to raise approximately £3 million
|
|
| | | Notice of Interest
|
|
| | | Further re: Board Appointment
|
|
| | | Board Appointment
|
|
| | | A single dose of RPL554 is safe and effective in patients with asthma
|
|
| | | Interim Results For The Six Months To 30 June 2009
|
|
| | | Interim Results For The Six Months To 30 June 2009
|
|
| | | Change in Adviser
|
|
| | | Update to Total Voting Rights
|
|
| | | Result of AGM
|
|
| | | Clinical Trial Update
|
